Analysis of Vaccinium Myrtillus Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global vaccinium myrtillus market is valued at US$ 369.3 million in 2024. The market is forecasted to expand at a CAGR of 6.9% to reach US$ 720.7 million by 2034.
Increased health consciousness, a rise in the incidence of chronic diseases, including diabetes and cardiovascular conditions, and a rise in the demand for natural and functional food components are driving market growth. The extract's anti-inflammatory and antioxidant qualities have made it popular, and it is now used in drinks, functional foods, and dietary supplements.
The creation of novel applications and the extension of the product's use in potentially high growth markets present growth prospects, as stated in the vaccinium myrtillus industry outlook. There are encouraging directions for further research given the extract's potential for weight control and cognitive wellness. Furthermore, it is anticipated that improvements in extraction and processing technologies will boost the effectiveness and quality of the final product, propelling market expansion even more.
Clean-label and plant-based components are becoming more popular, which fits in nicely with vaccinium myrtillus fruit extract's natural and health-promoting qualities. Future market trends are also influenced by the rising demand for goods that address certain health issues and the growing acceptance of customized nutrition, as per the vaccinium myrtillus industry analysis.
Worldwide demand for vaccinium myrtillus fruit extract is driven by consumers' growing awareness of the product's health advantages. Natural antioxidants included in vaccinium myrtillus fruit extract have been linked to several health advantages, such as better eyesight, less inflammation, and increased cognitive performance. It is anticipated that demand for vaccinium myrtillus fruit extract will keep rising as more people become aware of these advantages.
| Report Attribute | Detail |
|---|---|
| Vaccinium Myrtillus Market Size (2024E) | US$ 369.3 Million |
| Forecasted Market Value (2034F) | US$ 720.7 Million |
| Global Market Growth Rate (2024 to 2034) | 6.9% CAGR |
| Middle East & Africa Market Value (2024E) | US$ 16.3 Million |
| Japan Market Value (2034F) | US$ 28.3 Million |
| Fruit Extract Segment Growth Rate (2024 to 2034) | 7% CAGR |
| Food Segment Value (2034F) | US$ 291.1 Million |
| Key Companies Profiled | Eevia Health Oy; ETchem; Sanyuan Jinrui Natural Ingredients Co. Ltd; BioMax Life Sciences; NOW Foods; Bio-Botanica |
Vaccinium myrtillus is a relative of the blueberry, widely found in diverse areas, including the rocky mountains and regions of Asia and Europe. The growing use of vaccinium myrtillus as a dietary supplement for eye problems, cardiovascular conditions, diabetes, urinary tract infections, and diarrhea is creating lucrative growth opportunities for the stakeholders.
Extensive adoption of bilberry extract in drops, tablets, and capsules, in dried and powdered forms, is underpinning gains in the market, as per Fact.MR published a vaccinium myrtillus industry analysis. Growing traction for natural and organic ingredients in food and dietary supplements, backed by shifting consumer preference for clean-label products is providing impetus to the growth in the vaccinium myrtillus market.
Fact.MR published the vaccinium myrtillus industry outlook mentioned that the high health benefits of bilberry continue to drive growth in the market. However, according to the National Institutes of Health (NIH), researchers lack scientific evidence to back the use of this shrub for any kind of health condition.
The growing use of vaccinium myritillus coupled with the concerns pertaining to its effectiveness for medicinal uses has led companies to invest in its R&D. Researchers are keen to study vaccinium myrtillus on a large scale because their berries have a high concentration of antioxidants known as anthocyanins, which some studies suggest potentially have health benefits.
Companies are increasingly exploring the potentially viable applications of vaccinium myrtillus to gain an extra edge in the market. Increasing penetration of advanced technology in the R&D sector is bringing positive changes in the market.
Vaccinium myrtillus, commonly known as wimberry, bilberry, European blueberry, or whortleberry, is a species of shrubs with blue color edible fruit of high medicinal value. Vaccinium myrtillus is distinctly known as common bilberry or blue whortleberry to distinguish it from other vaccinium species.
Vaccinium myrtillus is majorly found in Europe, Greenland, Iceland, northern Asia, the U.S. and Canada. However, the majority of the vaccinium myrtillus is produced in Eastern Europe regions. Vaccinium myrtillus is majorly found in the wild in acidic soil conditions. Vaccinium myrtillus finds its application in several end-use industry verticals, and hence a positive outlook is witnessed for the market in the upcoming years.
The global scenario of increasing disease burden and extensive R&D efforts for the innovation of drugs are the prime factors supporting the explosively growing pharmaceutical industry world. According to the American Diabetes Association, over 30.3 million Americans were diagnosed with diabetes, which was proven to be the leading cause of death in the United States, in 2015.
With the increasing prevalence of diabetes, the demand for vaccinium myrtillus products is expected to witness a rise in the United States and other regions around the world.
According to a study published in the European Review for Medical and Pharmacological Sciences, vaccinium myrtillus is used to provide relief for dry eyes. It is used to reduce eye discomfort, where vaccinium myrtillus extracts play a vital role in improving tear secretion and plasmatic antioxidant potential in patients suffering from dry eye.
According to the University of Maryland Medical Center, vaccinium myrtillus is very rich in anthocyanosides, which helps in assisting the viability of blood vessels and ensures healthy circulation throughout the body, including capillaries in the eyes.
More comprehensive research on vaccinium myrtillus reveals anthocyanosides present in vaccinium myrtillus accelerate the formulation of the pigment called rhodopsin, which helps in the eyes’ ability to see in darkness as well as improves the adaptability of eyes towards changing light intensity.
Vaccinium myrtillus also helps delay cataract development and contains a significant amount of anthocyanosides, which assists in minimizing blood clots because of its properties to thwart blood platelets from aggregating.
Moreover, anthocyanosides are antioxidants and help in preventing the oxidizing of cholesterol. Improved vision, reduction in hemorrhagic tendencies in the eyes, and improved blood vessel structure are some of the factors because of which vaccinium myrtillus is widely used in the pharmaceutical industry.
The high medicinal properties of vaccinium myrtillus and increasing health-related issues will drive the vaccinium myrtillus in the forecast period. High demand for vaccinium myrtillus is seen in the upcoming years but there are some factors, which impede the overall growth of the market. Some factors include adulteration of vaccinium myrtillus extract.
Vaccinium myrtillus is often adulterated with intensive dark blue colors, such as anthocyanidin-containing extracts, or red food coloring, including amaranth dye. Such extracts and dyes are harmful to human consumption. In addition, rising global geopolitical tensions resulting in trade wars will negatively affect the overall growth of the vaccinium myrtillus market during the forecast period.
High demand for vaccinium myrtillus is seen in North America and Europe region. In the U.S., vaccinium myrtillus was among the top 20 herbal supplements between 2007 and 2012 in the food and pharmaceutical market. Asia Pacific and Latin America to register high CAGR during the forecast period.
Some of the leading manufacturers of vaccinium myrtillus include :
This analytical research study imparts an all-inclusive assessment of the market while propounding historical intelligence, actionable insights, and industry-validated & statistically upheld market forecasts. A verified and suitable set of assumptions and methodology has been leveraged for developing this comprehensive study. Information and analysis on key market segments incorporated in the report have been delivered in weighted chapters.
A thorough analysis has been offered by the report on :
Compilation of authentic and first-hand intelligence, insights offered in the report are based on quantitative and qualitative assessments by leading industry experts and inputs from opinion leaders & industry participants around the value chain.
Growth determinants, macroeconomic indicators, and parent market trends have been scrutinized and delivered, coupled with the market attractiveness for each market segment encompassed. The qualitative impact of growth influencers on the market segments across regions has also been mapped by the report.
Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness
What are the key factors driving the growth of the vaccinium myrtillus market?
With the increasing prevalence of diabetes, demand for vaccinium myrtillus products is projected to rise.
Who are the key players in the global market?
Some of the leading companies are Eevia Health Oy, ETchem, BioMax Life Sciences, NOW Foods, and Bio-Botanica.
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Product Type
Table 3: Global Market US$ Mn Forecast by End-Use Application
Table 4: Global Market US$ Mn Forecast by Nature
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Product Type
Table 7: North America Market US$ Mn Forecast by End-Use Application
Table 8: North America Market US$ Mn Forecast by Nature
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Product Type
Table 11: Latin America Market US$ Mn Forecast by End-Use Application
Table 12: Latin America Market US$ Mn Forecast by Nature
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Product Type
Table 15: Western Europe Market US$ Mn Forecast by End-Use Application
Table 16: Western Europe Market US$ Mn Forecast by Nature
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Product Type
Table 19: Eastern Europe Market US$ Mn Forecast by End-Use Application
Table 20: Eastern Europe Market US$ Mn Forecast by Nature
Table 21: Asia Pacific Market US$ Mn Forecast by Country
Table 22: Asia Pacific Market US$ Mn Forecast by Product Type
Table 23: Asia Pacific Market US$ Mn Forecast by End-Use Application
Table 24: Asia Pacific Market US$ Mn Forecast by Nature
Table 25: East Asia Market US$ Mn Forecast by Country
Table 26: East Asia Market US$ Mn Forecast by Product Type
Table 27: East Asia Market US$ Mn Forecast by End-Use Application
Table 28: East Asia Market US$ Mn Forecast by Nature
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Product Type
Table 31: MEA Market US$ Mn Forecast by End-Use Application
Table 32: MEA Market US$ Mn Forecast by Nature
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 22: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 23: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 24: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use Application
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Nature
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Vaccinium Myrtillus Market